Answer
ReQuip (ropinirole) treats Parkinson's disease, initially alone to delay introducing levodopa, or with levodopa when its effect wears off or becomes inconsistent with fluctuations in therapeutic effect.
Sources for this answer
- Requip 0.25 mg TabletsGlaxoSmithKline UK · emc · SmPC §4.1 Therapeutic Indications · Version 40Document updated
Sources checked